SMA9h
FDA approves new tablet version of oral SMA treatment Evrysdi
The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...
FDA approves new genetic disorder drug
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on ...
The FDA just approved a new painkiller. Is it too good to be true?
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
FDA approves Symbravo for acute treatment of migraine in adults
The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...
Palm Beach Post14d
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The drug, suzetrigine ... Journavx will be priced at $15.50 per pill. The FDA-approved medication, available as a 50-milligram prescription tablet taken every 12 hours, offers a non-opioid ...
rolltidewire.usatoday14d
FDA approves new pain medicine as opioid alternative. What to know about Journavx
Vertex Pharmaceuticals announced that Journavx will be priced at $15.50 per pill. The FDA-approved medication, available as a 50-milligram prescription tablet taken every 12 hours ... In 2021, the ...